222 related articles for article (PubMed ID: 32959474)
21. Cardiotoxicity of 5-fluorouracil.
Collins C; Weiden PL
Cancer Treat Rep; 1987; 71(7-8):733-6. PubMed ID: 3300968
[TBL] [Abstract][Full Text] [Related]
22. A new perspective on cardiotoxicity of 5-fluorouracil. A novel research tool 'cardiac ultrasonic integrated backscatter analysis' indicates transient, subclinical myocardial dysfunction due to high-dose leucovorin and infusional 5-fluorouracil regimen.
Barutca S; Ceyhan C; Meydan N; Ozturk B; Tekten T; Onbasili A; Kadikoylu G; Bolaman Z
Chemotherapy; 2004 Jun; 50(3):113-8. PubMed ID: 15272225
[TBL] [Abstract][Full Text] [Related]
23. Rare Presentation of Cardiotoxicity Related to 5-Fluorouracil.
Charkviani M; Murvelashvili N; Barrera F; Sharma A; Eldin RS; Nabil NUN
Case Rep Oncol Med; 2020; 2020():4151474. PubMed ID: 32774961
[TBL] [Abstract][Full Text] [Related]
24. [Cardiotoxicity of 5-fluorouracil: report of 6 cases].
Timour Q; Lombard-Bohas C; Slim R; Barel C; Bui-Xuan B; Tabib A; Bricca G; Malonne H; Vial T; Iordescu D; Descotes J
Therapie; 2002; 57(3):302-6. PubMed ID: 12422546
[TBL] [Abstract][Full Text] [Related]
25. [Acute cardiac toxicity of 5-fluorouracil: pharmacokinetic correlation].
Gamelin E; Gamelin L; Larra F; Turcant A; Alain P; Maillart P; Allain YM; Minier JF; Dubin J
Bull Cancer; 1991; 78(12):1147-53. PubMed ID: 1786427
[TBL] [Abstract][Full Text] [Related]
26. Ultra-Sensitive Copeptin and Cardiac Troponin in Diagnosing Non-ST-Segment Elevation Acute Coronary Syndromes--The COPACS Study.
Ricci F; Di Scala R; Massacesi C; Di Nicola M; Cremonese G; De Pace D; Rossi S; Griffo I; Cataldo I; Martinotti S; Rotondo D; Jaffe AS; Zimarino M; De Caterina R
Am J Med; 2016 Jan; 129(1):105-14. PubMed ID: 26169889
[TBL] [Abstract][Full Text] [Related]
27. Diagnosis and Management of a Patient With 5-Fluorouracil-Induced ST Elevation and Nonsustained Ventricular Tachycardia as a Late Presentation of Cardiotoxicity and Successful 5-Fluorouracil Rechallenge.
Medepalli LC; Mahmood TS; Liberman H; Medepalli AM; Bagwell TW
Cureus; 2022 Oct; 14(10):e30489. PubMed ID: 36415417
[TBL] [Abstract][Full Text] [Related]
28. Fluorouracil cardiotoxicity.
Anand AJ
Ann Pharmacother; 1994 Mar; 28(3):374-8. PubMed ID: 8193429
[TBL] [Abstract][Full Text] [Related]
29. Postoperative Cardiac Ischemia Detection by Continuous 12-Lead Electrocardiographic Monitoring in Vascular Surgery Patients: A Prospective, Observational Study.
Ollila A; Virolainen J; Vanhatalo J; Vikatmaa P; Tikkanen I; Venermo M; Salmenperä M; Pettilä V; Vikatmaa L
J Cardiothorac Vasc Anesth; 2017 Jun; 31(3):950-956. PubMed ID: 27919716
[TBL] [Abstract][Full Text] [Related]
30. Severity of silent myocardial ischemia on ambulatory electrocardiographic monitoring in patients with stable angina pectoris: relation to prognostic determinants during exercise stress testing and coronary angiography.
Mody FV; Nademanee K; Intarachot V; Josephson MA; Robertson HA; Singh BN
J Am Coll Cardiol; 1988 Nov; 12(5):1169-76. PubMed ID: 3170959
[TBL] [Abstract][Full Text] [Related]
31. Cardiotoxicity of 5-fluorouracil.
Alter P; Herzum M; Soufi M; Schaefer JR; Maisch B
Cardiovasc Hematol Agents Med Chem; 2006 Jan; 4(1):1-5. PubMed ID: 16529545
[TBL] [Abstract][Full Text] [Related]
32. Symptomatic cardiotoxicity with high-dose 5-fluorouracil infusion: a prospective study.
Akhtar SS; Salim KP; Bano ZA
Oncology; 1993; 50(6):441-4. PubMed ID: 8233284
[TBL] [Abstract][Full Text] [Related]
33. Fluorouracil induces myocardial ischemia with increases of plasma brain natriuretic peptide and lactic acid but without dysfunction of left ventricle.
Jensen SA; Hasbak P; Mortensen J; Sørensen JB
J Clin Oncol; 2010 Dec; 28(36):5280-6. PubMed ID: 21079148
[TBL] [Abstract][Full Text] [Related]
34. Myocardial ischemia, cardiac troponin, and long-term survival of high-cardiac risk critically ill intensive care unit patients.
Landesberg G; Vesselov Y; Einav S; Goodman S; Sprung CL; Weissman C
Crit Care Med; 2005 Jun; 33(6):1281-7. PubMed ID: 15942345
[TBL] [Abstract][Full Text] [Related]
35. [Perioperative myocardial infarction and cardiac complications after noncardiac surgery in patients with prior myocardial infarction. II: Perioperative long-term ECG--clinical relevance practicability].
Heim C; Geel A; Münzer T; Angehrn W; Roelli H; Niederhauser H
Anaesthesist; 1996 Mar; 45(3):220-4. PubMed ID: 8919893
[TBL] [Abstract][Full Text] [Related]
36. The spectrum of 5-fluorouracil cardiotoxicity.
McLachlan SA; Millward MJ; Toner GC; Guiney MJ; Bishop JF
Med J Aust; 1994 Aug; 161(3):207-9. PubMed ID: 8035725
[TBL] [Abstract][Full Text] [Related]
37. Cardiotoxicity of 5-fluorouracil in combination with folinic acid in patients with gastrointestinal cancer.
Schöber C; Papageorgiou E; Harstrick A; Bokemeyer C; Mügge A; Stahl M; Wilke H; Poliwoda H; Hiddemann W; Köhne-Wömpner CH
Cancer; 1993 Oct; 72(7):2242-7. PubMed ID: 8374883
[TBL] [Abstract][Full Text] [Related]
38. Capecitabine-induced coronary artery vasospasm in a patient who previously experienced a similar episode with fluorouracil therapy.
Karakulak UN; Aladağ E; Maharjan N; Övünç K
Turk Kardiyol Dern Ars; 2016 Jan; 44(1):71-4. PubMed ID: 26875134
[TBL] [Abstract][Full Text] [Related]
39. Fluoropyrimidine Cardiotoxicity: Time for a Contemporaneous Appraisal.
Upshaw JN; O'Neill A; Carver JR; Dimond EP; Denlinger CS; Kircher SM; Wagner LI; Ky B; Brell JM
Clin Colorectal Cancer; 2019 Mar; 18(1):44-51. PubMed ID: 30348619
[TBL] [Abstract][Full Text] [Related]
40. Severe ventricular dysrhythmias and silent ischemia during infusion of the antimetabolite 5-fluorouracil and cis-platin.
Hrovatin E; Viel E; Lestuzzi C; Tartuferi L; Zardo F; Brieda M; Dametto E; Piazza R; Antonini-Canterin F; Vaccher E; Meneguzzo N; Nicolosi GL
J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):637-40. PubMed ID: 16858245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
